← Back to Clinical Trials
Recruiting NCT06593184

NCT06593184 Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06593184
Status Recruiting
Phase
Sponsor Universidade Federal de Pernambuco
Condition Stroke Sequelae
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-06-01
Primary Completion 2025-06-01

Trial Parameters

Condition Stroke Sequelae
Sponsor Universidade Federal de Pernambuco
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2024-06-01
Completion 2025-06-01
Interventions
Trans-spinal magnetic stimulationSham Comparator

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if trans-spinal magnetic stimulation works to treat gait disorders in chronic stroke adults. It will also learn about the safety of trans-spinal magnetic stimulation. The main questions it aims to answer are: Does trans-spinal magnetic stimulation enhance chronic stroke participants gait and functional mobility? Does the technique cause any side effects? Researchers will compare trans-spinal magnetic stimulation to a sham (a look-alike stimulation with no real effect) to see if trans-spinal magnetic stimulation works to treat gait disorders and improve functional mobility. Participants will: Receive trans-spinal magnetic stimulation with treadmill training or a sham stimulation with treadmill training every day for 2 weeks.

Eligibility Criteria

Inclusion Criteria: * Confirmation of Stroke by digital or physical imaging or medical report * Gait impairment * Stroke with at least 6 months after ictus Exclusion Criteria: * Metallic implants in spinal cord * Major orthopedic/rheumatological disorders * Incapacity of verbal or non-verbal communication

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology